Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
Clinical trial NCT04905810 · RECRUITING
Trial details
- NCT number
- NCT04905810
- Sponsor
- Brian Jonas
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2025-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.